Shares of British animal genetics firm Genus shot up nearly 29% on Thursday, after it reported a 38% surge in annual adjusted pretax profit, on a constant currency basis.
Genus plc (OTCPK:GENSF) Q2 2025 Earnings Conference Call February 27, 2025 3:30 AM ET Company Participants Jorgen Kokke - CEO Alison Henriksen - CFO Conference Call Participants Charles Hall - Peel Hunt Seb Jantet - Panmure Liberum Limited Sean Conroy - Shore Capital Damian McNeela - Deutsche Bank Christian Glennie - Stifel Alex Jones - Bank of America Edward Sham - Singer Capital Markets Jorgen Kokke Good morning, everyone. Thank you very much for joining us here at Buchanan.
| Biotechnology Industry | Healthcare Sector | Mr. Jorgen Kokke CEO | OTC PINK Exchange | GB0002074580 ISIN |
| GB Country | 3,500 Employees | 7 Mar 2025 Last Dividend | - Last Split | - IPO Date |
Genus plc is a pioneering animal genetics company that holds a prominent position in the global market with operations spanning North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. Incorporated in 1994 and headquartered in Basingstoke, United Kingdom, the company has carved a niche for itself through its dedicated efforts in advancing animal breeding and genetics. The business model of Genus plc is structured around three primary segments: Genus PIC, which focuses on porcine genetics; Genus ABS, which specializes in cattle genetics; and Genus Research and Development, which spearheads innovations in animal genetics. Through its comprehensive range of products and unparalleled technical services, Genus plc aims to enhance the productivity and sustainability of the meat and dairy industries.
Under the PIC brand, Genus plc offers high-quality breeding pigs and pig semen, tailored to meet the diverse needs of pork production. These genetics solutions are designed to produce pigs with specific characteristics, such as improved growth rates, feed efficiency, and meat quality, helping farmers increase their profitability and meet the growing global demand for pork.
The company sells a comprehensive range of bull semen and embryos under the ABS, Genus, and Bovec brands, aiming to enhance the genetics of the dairy and beef herds. These products enable breeders to produce calves with desired traits, such as higher milk production for dairy cows and improved meat quality for beef cattle, contributing to the efficiency and sustainability of dairy and beef production.
In addition to its genetics products, Genus plc offers an extensive array of technical services to farmers. These services are designed to support farmers in maximizing the genetic potential of their herds, improving animal health and productivity, and enhancing overall farm management. This hands-on support ensures that customers can achieve the full benefits of Genus plc's animal genetics technologies.